You are here

The Progress Report Keep up-to-date with our community. From science coverage to fundraiser spotlights, get the latest news here.

BCRF_Research_374

NEW YORK, NY – December 11, 2019 – The Breast Cancer Research Foundation (BCRF) announced $5 million in funding provided by Eli Lilly and Company to conduct investigator-initiated studies of the CDK4 & 6 inhibitor, Verzenio® (abemaciclib).

An upcoming clinical trial will evaluate the use of contrast enhanced mammography as a breast cancer screening option for women with dense breast tissue
Tags:
Raise money for lifesaving research this holiday season and throughout the new year.
BCRF attended the fifth annual Conquer Cancer Scientific and Career Development Retreat designed to empower early career researchers.
Group Photo
Learn how you can become a Team BCRF runner in this year’s 13.1-mile race
Tags:
Carol Chaoui who is living with metastatic breast cancer, will participate in the race with her daughter, Lina.
Pink Press Fall 2019
The inspiration of a BCRF metastasis researcher, recaps from signature events, ASCO 2019 science updates and more
BCRF Corporate Partners offer simple ways to give back this month and beyond.
Nina Garcia at BCRF
The Editor-in-Chief of ELLE magazine will host BCRF's upcoming Symposium & Awards Luncheon